Skip to main content

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

July 2018 - First Report Managed Care

Column

Viewpoint
07/20/2018
For specialty pharmacies who are excelling at high-touch, white glove, patient care—now is the time to take these conversations forward and be the ones who bring together each of the spokes on the wheel, including biopharma partners, payers,...
For specialty pharmacies who are excelling at high-touch, white glove, patient care—now is the time to take these conversations forward and be the ones who bring together each of the spokes on the wheel, including biopharma partners, payers,...
For specialty pharmacies who are...
07/20/2018
First Report Managed Care

Department

Managed Care Q&A
07/20/2018
An interview with Russel J Spjut, PharmD, formulary management clinical pharmacist and consultant at Formulary Intel Consulting.
An interview with Russel J Spjut, PharmD, formulary management clinical pharmacist and consultant at Formulary Intel Consulting.
An interview with Russel J...
07/20/2018
First Report Managed Care
Formulary Frontlines®
07/20/2018
Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...
Sarah M Temkin, MD, and Don Dizon, MD, discuss the benefits of PARP inhibitors for treating ovarian cancer and why effectiveness, toxicity, safety, and cost must be balanced for an individual patient to determine the right PARP inhibitor for...
Sarah M Temkin, MD, and Don...
07/20/2018
First Report Managed Care
Conference Insider
07/19/2018
A systematic review of value-based health care delivery models in oncology care presented at the American Society of Clinical Oncology (ASCO) Annual Meeting found that reports of outcomes are often lacking and show varying degrees of quality...
A systematic review of value-based health care delivery models in oncology care presented at the American Society of Clinical Oncology (ASCO) Annual Meeting found that reports of outcomes are often lacking and show varying degrees of quality...
A systematic review of...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
According to a presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat...
According to a presentation at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, results from a randomized controlled trial were compared with a real-world cohort for the safety and efficacy of a biosimilar to treat...
According to a presentation at...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting found that telehealth-based genetic counseling and mandatory discussion of genetic counseling referral at the time of treatment planning improved...
A study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting found that telehealth-based genetic counseling and mandatory discussion of genetic counseling referral at the time of treatment planning improved...
A study presented at the 2018...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma, according to a study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. 
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma, according to a study presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting. 
A new study attempted to...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
Daily text message reminders for patients with gout who were prescribed allopurinol significantly improved adherence and outcomes, according to research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018).
Daily text message reminders for patients with gout who were prescribed allopurinol significantly improved adherence and outcomes, according to research presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018).
Daily text message reminders for...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A 23-year follow-up study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that early, intensive rheumatoid arthritis (RA) intervention with combination therapy demonstrated long term benefits and reduced...
A 23-year follow-up study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) found that early, intensive rheumatoid arthritis (RA) intervention with combination therapy demonstrated long term benefits and reduced...
A 23-year follow-up study...
07/19/2018
First Report Managed Care
Conference Insider
07/19/2018
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) examined how non-medical switching from originator biologic products to biosimilar products could increase or neutralize costs due to increased resource...
A study presented at the 2018 Annual European Congress of Rheumatology (EULAR 2018) examined how non-medical switching from originator biologic products to biosimilar products could increase or neutralize costs due to increased resource...
A study presented at the 2018...
07/19/2018
First Report Managed Care

Advertisement

Advertisement

Advertisement